AI Platform (AIP001)— 510(k) K232501
Substantially EquivalentExo, Inc.
FDA 510(k) clearance K232501 for AI Platform (AIP001), Substantially Equivalent on 2023-11-17. Applicant: Exo, Inc..
Clearance details
- Applicant
- Exo, Inc.
- Product code
- Code QIH
- Advisory panel
- Radiology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Santa Clara, CA, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.